10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
65.05
+5.77 (9.73%)
At close: Nov 9, 2026, 4:00 PM EST
65.84
+0.79 (1.21%)
After-hours: Nov 9, 2026, 7:55 PM EST
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $8.56 billion as of November 9, 2026. It is the 2,406th most valuable company in the world and the 841st biggest in the United States. Its market cap has increased by 343.35% in one year.
Market Cap
8.56B
Enterprise Value
8.06B
1-Year Change
343.35%
Global Rank
Country Rank
#841 United States
Category
ChartMarket Cap Chart
Since September 12, 2019, 10x Genomics's market cap has increased from $4.95B to $8.56B, an increase of 72.83%. That is a compound annual growth rate of 7.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 8.56B | 314.53% |
| Dec 31, 2025 | 2.06B | 18.74% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glaukos | 13.28B |
| Smith & Nephew | 12.99B |
| Penumbra | 12.58B |
| Bio-Rad Laboratories | 10.26B |
| Bio-Rad Laboratories | 10.25B |
| Insulet | 10.16B |
| Globus Medical | 9.41B |
| Bruker | 9.34B |